Of notice, although there were modest correlations between ceramide score and levels of CRP and IL-6, controlling for these factors did not materially change the significant ceramide-MetS association, implying that the ceramide-associated metabolic disorder might not fully overlap with inflammation-mediated pathways. Here, IL6 is linked to metabolic disease.